BioSpace News Archive

How to Negotiate if Lowballed in a Job Offer

There are ways to negotiate a better starting salary if an employer lowballs you. Here are two of the most effective ways of going about it.

January 26, 2022
·
4 min read
·
Brandi Marcene
Drug Development

Global Roundup: Norway’s Cytovation Snags $20 Million in a Series A

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

January 26, 2022
·
6 min read
·
Alex Keown
Business

Axion BioSystems Welcomes Industry Leader David Ferrick as New CSO

Axion BioSystems, a leading life science tools company, has announced the appointment of David Ferrick as Chief Scientific Officer.

January 26, 2022
·
2 min read
Bio-Implants Market: Key Trends & Competitive Analysis 2021-2031

The pursuit for improved biocompatibility and patient response to implants continues to be a topic of research in the clinical scenario.

January 26, 2022
·
5 min read
Business

Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada

Idorsia Ltd and Syneos Health® announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and Canada.

January 26, 2022
·
7 min read
New Study published showing Nevisense impact on clinician confidence and accuracy

SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders, announced that a new study supporting the use of Nevisense in diagnosing melanoma has been published in “SKIN - The journal of cutaneous medicine”.

January 26, 2022
·
3 min read
MRM Health to Present at the 6th Microbiome Movement Drug Development Europe Summit

MRM Health announced that it will present scientific data from its portfolio at the 6th Microbiome Movement Drug Development Europe Summit, resulting from its proprietary and unique CORAL™ platform technology.

January 26, 2022
·
3 min read
Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline

Prokarium has entered into an agreement, through Imperial Projects, to work with independent researchers from Imperial College London to develop Prokarium’s next-generation therapeutic candidates, engineered to deliver payloads within the tumor microenvironment.

January 26, 2022
·
2 min read
Pharm Country

BioRestorative Therapies Named One of Ten Most Innovative Regenerative Medicine Companies in 2022 by Insights Care Magazine

BioRestorative Therapies, Inc. today announced that it has been named by Insights Care Magazine as one of the ten most innovative regenerative medicine companies in 2022 for its work in developing novel cell-based therapeutics.

January 26, 2022
·
3 min read
Biotech Bay

Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures

Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for serious autoimmune diseases, announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures.

January 26, 2022
·
5 min read